From signal transduction to signal interpretation: An alternative model for the molecular function of insulin receptor substrates

Archives of Physiology and Biochemistry

Volumn 118, Issue 3, 2012, Pages 148-155

  Boller, Simone ^a   Joblin, Bradley A ^a   Xu, Linhua ^a   Item, Flurin ^b   Trüb, Thomas ^a   Boschetti, Nicola ^a   Spinas, Giatgen A ^a,c   Niessen, Markus ^a,c  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^c ETH ZURICH   (Switzerland)

Author keywords

Diabetes; Insulin resistance; Insulin signalling; IRS; Signalling networks

Indexed keywords

INSULIN RECEPTOR; INSULIN RECEPTOR SUBSTRATE; TYROSINE;

ANIMAL; BINDING SITE; BIOLOGICAL MODEL; GENE EXPRESSION REGULATION; GENETICS; HUMAN; INSULIN RESISTANCE; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY; PROTEIN BINDING; PROTEIN TERTIARY STRUCTURE; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; BINDING SITES; DIABETES MELLITUS, TYPE 2; GENE EXPRESSION REGULATION; HUMANS; INSULIN RECEPTOR SUBSTRATE PROTEINS; INSULIN RESISTANCE; MODELS, BIOLOGICAL; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; RECEPTOR, INSULIN; SIGNAL TRANSDUCTION; TYROSINE;

EID: 84862543951     PISSN: 13813455     EISSN: 17444160     Source Type: Journal    
DOI: 10.3109/13813455.2012.671333     Document Type: Review

References (68)

1. Aguirre V, Uchida T, Yenush L, Davis R, White MF. (2000). Te c-Jun NH(2)-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser(307). J Biol Chem 275:9047-54.
2. Araki E, Lipes MA, Patti ME, Bruning JC, Haag 3rd B, Johnson RS, Kahn CR. (1994). Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene. Nature 372:186-90.
3. Arkan MC, Hevener AL, Greten FR, Maeda S, Li ZW, Long JM, Wynshaw-Boris A, Poli G, Olefsky J, Karin M. (2005). IKK-beta links inflammation to obesity-induced insulin resistance. Nat Med 11:191-8.
4. Avruch J. (1998). Insulin signal transduction through protein kinase cascades. Mol Cell Biochem 182:31-48.
5. Bandyopadhyay G, Kanoh Y, Sajan MP, Standaert ML, Farese RV. (2000). Effects of adenoviral gene transfer of wild-type, constitutively active, and kinase-defective protein kinase C-lambda on insulin-stimulated glucose transport in L6 myotubes. Endocrinology 141:4120-27.
6. Bandyopadhyay G, Sajan MP, Kanoh Y, Standaert ML, Quon MJ, Lea-Currie R, Sen A, Farese RV. (2002). PKC-zeta mediates insulin effects on glucose transport in cultured preadipocyte-derived human adipocytes. J Clin Endocrinol Metab 87:716-23.
7. Bhalla US, Iyengar R. (1999). Emergent properties of networks of biological signaling pathways. Science 283:381-7.
8. Borge Jr PD, Wolf BA. (2003). Insulin receptor substrate 1 regulation of sarco-endoplasmic reticulum calcium ATPase 3 in insulin-secreting beta-cells. J Biol Chem 278:11359-68.
9. Boura-Halfon S, Zick Y. (2009). Phosphorylation of IRS proteins, insulin action, and insulin resistance. Am J Physiol Endocrinol Metab 296:E581-91.
10. Bouzakri K, Zachrisson A, Al-Khalili L, Zhang BB, Koistinen HA, Krook A, Zierath JR. (2006). siRNA-based gene silencing reveals specialized roles of IRS-1/Akt2 and IRS-2/Akt1 in glucose and lipid metabolism in human skeletal muscle. Cell Metab 4:89-96.
11. Chiu TT, Jensen TE, Sylow L, Richter EA, Klip A. (2011). Rac1 signalling towards GLUT4/glucose uptake in skeletal muscle. Cell Signal 23:1546-54.
12. Chong M P, Barritt GJ, Crouch MF. (2004). Insulin potentiates EGFR activation and signaling in fibroblasts. Biochem Biophys Res Commun 322:535-41.
13. Copps KD, Hancer NJ, Opare-Ado L, Qiu W, Walsh C, White MF. (2010). Irs1 serine 307 promotes insulin sensitivity in mice. Cell Metab 11:84-92.
14. Crouch MF, Davy DA, Willard FS, Berven LA. (2000). Insulin induces epidermal growth factor (EGF) receptor clustering and potentiates EGF-stimulated DNA synthesis in Swiss 3T3 cells: a mechanism for costimulation in mitogenic synergy. Immunol Cell Biol 78:408-14.
15. de Alvaro C, Teruel T, Hernandez R, Lorenzo M. (2004). Tumor necrosis factor alpha produces insulin resistance in skeletal muscle by activation of inhibitor kappaB kinase in a p38 MAPK-dependent manner. J Biol Chem 279:17070-78.
16. Dietze D, Ramrath S, Ritzeler O, Tennagels N, Hauner H, Eckel J. (2004). Inhibitor kappaB kinase is involved in the paracrine crosstalk between human fat and muscle cells. Int J Obes Relat Metab Disord 28:985-92.
17. Ediger TL, Toews ML. (2000). Synergistic stimulation of airway smooth muscle cell mitogenesis. J Pharmacol Exp Ter 294:1076-82.
18. Fantin VR, Wang Q, Lienhard GE, Keller SR. (2000). Mice lacking insulin receptor substrate 4 exhibit mild defects in growth, reproduction, and glucose homeostasis. Am J Physiol Endocrinol Metab 278:E127-33.
19. Gao Z, Hwang D, Bataille F, Lefevre M, York D, Quon MJ, Ye J. (2002). Serine phosphorylation of insulin receptor substrate 1 by inhibitor kappa B kinase complex. J Biol Chem 277:48115-21.
20. Gogg S, Smith U. (2002). Epidermal growth factor and transforming growth factor alpha mimic the effects of insulin in human fat cells and augment downstream signaling in insulin resistance. J Biol Chem 277:36045-51.
21. Hanke S, Mann M. (2009). Te phosphotyrosine interactome of the insulin receptor family and its substrates IRS-1 and IRS-2. Mol Cell Proteomics 8:519-34.
22. Herschkovitz A, Liu Y F, Ilan E, Ronen D, Boura-Halfon S, Zick Y. (2007). Common inhibitory serine sites phosphorylated by IRS-1 kinases, triggered by insulin and inducers of insulin resistance. J Biol Chem 282:18018-27.
23. Hoehn KL, Hohnen-Behrens C, Cederberg A, Wu LE, Turner N, Yuasa T, Ebina Y, James DE. (2008). IRS1-independent defects define major nodes of insulin resistance. Cell Metab 7:421-33.
24. Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM. (1995). Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest 95:2409-15.
25. Hotamisligil GS, Spiegelman BM. (1994). Tumor necrosis factor alpha: a key component of the obesity-diabetes link. Diabetes 43: 1271-8.
26. Huang C, Tirone AC, Huang X, Klip A. (2005). Differential contribution of insulin receptor substrates 1 versus 2 to insulin signaling and glucose uptake in l6 myotubes. J Biol Chem 280:19426-35.
27. Ish-Shalom D, Christoffersen CT, Vorwerk P, Sacerdoti-Sierra N, Shymko RM, Naor D, De Meyts P. (1997). Mitogenic properties of insulin and insulin analogues mediated by the insulin receptor. Diabetologia 40 Suppl 2:S25-31.
28. Ishii K, Kamohara S, Hayashi H, Todaka M, Kanai F, Imanaka T, Ebina Y. (1994). Epidermal growth factor triggers the translocation of insulin-responsive glucose transporter (GLUT4). Biochem Biophys Res Commun 205:857-63.
29. Kahn SE, Hull RL, Utzschneider KM. (2006). Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 444:840-46.
30. Klein AL, Berkaw MN, Buse MG, Ball LE. (2009). O-linked N-acetylglucosamine modification of insulin receptor substrate-1 occurs in close proximity to multiple SH2 domain binding motifs. Mol Cell Proteomics 8:2733-45.
31. Kotzka J, Lehr S, Roth G, Avci H, Knebel B, Muller-Wieland D. (2004). Insulin-activated Erk-mitogen-activated protein kinases phosphorylate sterol regulatory element-binding Protein-2 at serine residues 432 and 455 in vivo. J Biol Chem 279: 22404-11.
32. Kruger M, Linke WA. (2011). Te giant protein titin: a regulatory node that integrates myocyte signaling pathways. J Biol Chem 286:9905-12.
33. Kubota N, Tobe K, Terauchi Y, Eto K, Yamauchi T, Suzuki R, Tsubamoto Y, Komeda K, Nakano R, Miki H et al. (2000). Disruption of insulin receptor substrate 2 causes type 2 diabetes because of liver insulin resistance and lack of compensatory beta-cell hyperplasia. Diabetes 49:1880-89.
34. Lehr S, Hartwig S, Lamers D, Famulla S, Muller S, Hanisch FG, Cuvelier C, Ruige J, Eckardt K, Ouwens DM et al. (2012). Identification and validation of novel adipokines released from primary human adipocytes. Mol Cell Proteomics 11:1-13.
35. Lemmon MA, Schlessinger J. (2010). Cell signaling by receptor tyrosine kinases. Cell 141:1117-34.
36. Liu SC, Wang Q, Lienhard GE, Keller SR. (1999). Insulin receptor substrate 3 is not essential for growth or glucose homeostasis. J Biol Chem 274:18093-9.
37. Martin S, Parton RG. (2006). Lipid droplets: a unified view of a dynamic organelle. Nat Rev Mol Cell Biol 7:373-8.
38. Mikus CR, Oberlin DJ, Libla JL, Taylor AM, Booth FW, Tyfault JP. (2011). Lowering Physical Activity Impairs Glycemic Control in Healthy Volunteers. Med Sci Sports Exerc 44:225-31.
39. Miller MK, Bang ML, Witt CC, Labeit D, Trombitas C, Watanabe K, Granzier H, McElhinny AS, Gregorio CC, Labeit S. (2003). Te muscle ankyrin repeat proteins: CARP, ankrd2/Arpp and DARP as a family of titin filament-based stress response molecules. J Mol Biol 333:951-64.
40. Mohanty S, Spinas GA, Maedler K, Zuellig RA, Lehmann R, Donath MY, Trub T, Niessen M. (2005). Overexpression of IRS2 in isolated pancreatic islets causes proliferation and protects human beta-cells from hyperglycemia-induced apoptosis. Exp Cell Res 303:68-78.
41. Ozcan U, Cao Q, Yilmaz E, Lee AH, Iwakoshi NN, Ozdelen E, Tuncman G, Gorgun C, Glimcher LH, Hotamisligil GS. (2004). Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes. Science 306:457-61.
42. Papa V, Costantino A, Belfiore A. (1997). Insulin receptor what role in breast cancer? Trends Endocrinol Metab 8:306-12.
43. Perz M, Torlinska T. (2001). Insulin receptor - structural and functional characteristics. Med Sci Monit 7:169-77.
44. Pirola L, Johnston AM, Van Obberghen E. (2004). Modulation of insulin action. Diabetologia 47:170-84.
45. Roberts CK, Won D, Pruthi S, Kurtovic S, Sindhu RK, Vaziri ND, Barnard RJ. (2006). Effect of a short-term diet and exercise intervention on oxidative stress, inflammation, MMP-9, and monocyte chemotactic activity in men with metabolic syndrome factors. J Appl Physiol 100:1657-65.
46. Roth G, Kotzka J, Kremer L, Lehr S, Lohaus C, Meyer HE, Krone W, Muller-Wieland D. (2000). MAP kinases Erk1/2 phosphorylate sterol regulatory element-binding protein (SREBP)-1a at serine 117 in vitro. J Biol Chem 275:33302-7.
47. Ryden M, Arvidsson E, Blomqvist L, Perbeck L, Dicker A, Arner P. (2004). Targets for TNF-alpha-induced lipolysis in human adipocytes. Biochem Biophys Res Commun 318:168-75.
48. Rytka JM, Wueest S, Schoenle EJ, Konrad D. (2011). Te portal theory supported by venous drainage-selective fat transplantation. Diabetes 60:56-63.
49. Sabio G, Kennedy NJ, Cavanagh-Kyros J, Jung DY, Ko HJ, Ong H, Barrett T, Kim JK, Davis RJ. (2010). Role of muscle c-Jun NH2-terminal kinase 1 in obesity-induced insulin resistance. Mol Cell Biol 30:106-15.
50. Sajan MP, Rivas J, Li P, Standaert ML, Farese R V. (2006). Repletion of atypical protein kinase C following RNA interference-mediated depletion restores insulin-stimulated glucose transport. J Biol Chem 281:17466-73.
51. Sell H, Eckel J. (2010). Adipose tissue inflammation: novel insight into the role of macrophages and lymphocytes. Curr Opin Clin Nutr Metab Care 13:366-70.
52. Shoelson SE, Lee J, Yuan M. (2003). Inflammation and the IKK beta/I kappa B/NF-kappa B axis in obesity- and diet-induced insulin resistance. Int J Obes Relat Metab Disord 27 Suppl 3:S49-52.
53. Siddle K. (2011). Signalling by insulin and IGF receptors: supporting acts and new players. J Mol Endocrinol 47:R1-10.
54. Tamemoto H, Kadowaki T, Tobe K, Yagi T, Sakura H, Hayakawa T, Terauchi Y, Ueki K, Kaburagi Y, Satoh S et al. (1994). Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1. Nature 372:182-6.
55. Taniguchi CM, Emanuelli B, Kahn CR. (2006). Critical nodes in signalling pathways: insights into insulin action. Nat Rev Mol Cell Biol 7:85-96.
56. Taniguchi CM, Ueki K, Kahn R. (2005). Complementary roles of IRS-1 and IRS-2 in the hepatic regulation of metabolism. J Clin Invest 115:718-27.
57. Tirone AC, Huang C, Klip A. (2006). Tissue-specific roles of IRS proteins in insulin signaling and glucose transport. Trends Endocrinol Metab 17:72-8.
58. Trayhurn P, Drevon CA, Eckel J. (2011). Secreted proteins from adipose tissue and skeletal muscle - adipokines, myokines and adipose/muscle cross-talk. Arch Physiol Biochem 117:47-56.
59. Versteyhe S, Blanquart C, Hampe C, Mahmood S, Christeff N, De Meyts P, Gray SG, Issad T. (2010). Insulin receptor substrates-5 and -6 are poor substrates for the insulin receptor. Mol Med Report 3:189-93.
60. Welch EJ, Jones BW, Scott JD. (2010). Networking with AKAPs: context-dependent regulation of anchored enzymes. Mol Interv 10:86-97.
61. White MF. (1997). Te insulin signalling system and the IRS proteins. Diabetologia 40:S2-17.
62. White MF. (2002). IRS proteins and the common path to diabetes. American Journal of Physiology, Endocrinology and Metabolism 283:E413-22.
63. Whitehead JP, Molero JC, Clark S, Martin S, Meneilly G, James DE. (2001). Te role of Ca2+ in insulin-stimulated glucose transport in 3T3-L1 cells. J Biol Chem 276:27816-24.
64. Withers DJ, Gutierrez JS, Towery H, Burks DJ, Ren JM, Previs S, Zhang Y, Bernal D, Pons S, Shulman GI et al. (1998). Disruption of IRS-2 causes type 2 diabetes in mice. Nature 391:900-904.
65. Xu L, Spinas GA, Niessen M. (2010). ER stress in adipocytes inhibits insulin signaling, represses lipolysis, and alters the secretion of adipokines without inhibiting glucose transport. Horm Metab Res 42:643-51.
66. Yenush L, White MF. (1997). Te IRS-signalling system during insulin and cytokine action. Bioessays 19:491-500.
67. Yuan M, Konstantopoulos N, Lee J, Hansen L, Li ZW, Karin M, Shoelson SE. (2001). Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta. Science 293:1673-7.
68. Zhou AX, Hartwig JH, Akyurek LM. (2010). Filamins in cell signaling, transcription and organ development. Trends Cell Biol 20: 113-23.